Detalhe da pesquisa
1.
Plasma IgG aggregates as biomarkers for multiple sclerosis.
Clin Immunol
; 256: 109801, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816415
2.
Senescent-like microglia limit remyelination through the senescence associated secretory phenotype.
bioRxiv
; 2024 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38826296
3.
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination.
Ann Clin Transl Neurol
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713096
4.
SARS-CoV-2 Vaccine-Elicited Immunity after B Cell Depletion in Multiple Sclerosis.
Immunohorizons
; 8(3): 254-268, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483384
5.
SARS-CoV-2 mRNA vaccination induces an antigen-specific T cell response correlating with plasma interferon-gamma in B cell depleted patients.
J Neuroimmunol
; 383: 578192, 2023 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666038
6.
Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related Reactions.
Mult Scler J Exp Transl Clin
; 8(1): 20552173211069359, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35024160
7.
Proinflammatory cytokines and matrix metalloproteinases in CSF of patients with VZV vasculopathy.
Neurol Neuroimmunol Neuroinflamm
; 3(4): e246, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27340684